Trade BLTE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Belite Bio, Inc American Depositary Shares (BLTE) is trading at US$155.61, down 2.24% today as of Oct 6, 16:00 EDT. The company has a market capitalisation of US$6.49B. Over the past 52 weeks, BLTE has traded between US$76.23 and US$200.00. On Syfe you can trade BLTE with $0 commission and add it to your watchlist.
| Previous close | US$159.18 |
|---|---|
| Market cap | US$6.49B |
| P/E ratio | 221.33 |
| 52-week range | US$76.23 – US$200.00 |
| Volume | 190.14K |
| Exchange | US |
Belite Bio, Inc American Depositary Shares
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Year: 2022
Belite Bio Shares Rise After Canaccord Initiates Coverage With Buy Rating
Sep 4, 7:30 PM · MT Newswires
Belite Bio's Tinlarebant Revenue Estimates Have Multiple Drivers of Upside, Mizuho Says
Sep 4, 3:45 PM · MT Newswires
Stay on top of BLTE
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
